We are live on ! Find out more
PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Pear Therapeutics, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 53 → 1 (-52)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $20.7M → $0 (-$20.7M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 52

Holders
1
Holders Change
-52
Holders Change %
-98.11%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
52
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
-$6.83M
2
5VM
5AM Venture Management
California
-$4.27M
3
SoftBank Group
SoftBank Group
Japan
-$3.09M
4
AV
Arboretum Ventures
Michigan
-$2.77M
5
BlackRock
BlackRock
New York
-$857K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
– -$9.51K -37,296 Closed
Barclays
27
Barclays
United Kingdom
– -$9.13K -35,820 Closed
Renaissance Technologies
28
Renaissance Technologies
New York
– -$9K -34,600 Closed
AIG
29
American International Group
New York
– -$8.56K -33,579 Closed
Fidelity Investments
30
Fidelity Investments
Massachusetts
– -$8.46K -33,192 Closed
Goldman Sachs
31
Goldman Sachs
New York
– -$7.79K -30,549 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
– -$7.69K -30,170 Closed
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$7.45K -29,233 Closed
VOYA Investment Management
34
VOYA Investment Management
Georgia
– -$7.23K -28,358 Closed
Squarepoint
35
Squarepoint
New York
– -$7.07K -27,705 Closed
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
– -$6.6K -25,867 Closed
TRCT
37
Tower Research Capital (TRC)
New York
– -$6K -22,982 Closed
Invesco
38
Invesco
Georgia
– -$4.12K -16,161 Closed
SO
39
STRS Ohio
Ohio
– -$4K -15,900 Closed
Wells Fargo
40
Wells Fargo
California
– -$3.68K -14,441 Closed
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
– -$3 -12,000 Closed
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
– -$3K -11,499 Closed
AB
43
Amalgamated Bank
New York
– -$3K -10,851 Closed
Legal & General Group
44
Legal & General Group
United Kingdom
– -$1.84K -7,198 Closed
AIP
45
Ameritas Investment Partners
Nebraska
– -$1.37K -5,373 Closed
BWM
46
BerganKDV Wealth Management
Minnesota
– -$1.15K -4,500 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– -$1K -4,266 Closed
RAM
48
Riggs Asset Management
Pennsylvania
– -$765 -3,000 Closed
WTA
49
Washington Trust Advisors
Massachusetts
– -$765 -3,000 Closed
Osaic Holdings
50
Osaic Holdings
Arizona
– -$741 -2,908 Closed
1
2
3

PEAR Hedge Fund Activity: Q2 2023 in Review

1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Class A Common Stock (PEAR) for Q2 2023, worth a combined $0 — down 100% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of PEAR and 0 opened new positions — a net loss of 52 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Temasek Holdings, exiting entirely with an estimated $6.83M sold.

  • 1 institutional investor held Pear Therapeutics, Inc. Class A Common Stock (PEAR) as of Q2 2023, down from 53 in Q1 2023.
  • Funds reported $0 of Pear Therapeutics, Inc. Class A Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Pear Therapeutics, Inc. Class A Common Stock positions in Q2 2023 and 52 closed out, a net change of -52 holders.
  • The largest Pear Therapeutics, Inc. Class A Common Stock seller in Q2 2023 was Temasek Holdings, an estimated $6.83M sold.

Based on aggregated 13F filings for Q2 2023.